μ-Calpain is involved in the regulation of TNF-α-induced matrix metalloproteinase-3 release in a rheumatoid synovial cell line

Biochemical and Biophysical Research Communications

Volumn 343, Issue 3, 2006, Pages 937-942

  Morita, Masaji ^a   Banno, Yoshiko ^a   Dohjima, Taikoh ^a   Nozawa, Satoshi ^a   Fushimi, Kazunari ^a   Fan, De Gang ^a   Ohno, Takatoshi ^a   Miyazawa, Keiji ^b   Liu, Naxin ^a   Shimizu, Katsuji ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Calpain; Matrix metalloproteinase 3; Small interfering RNA; Synovial cell

Indexed keywords

CALPAIN; CALPASTATIN; CALPEPTIN; M CALPAIN; MU CALPAIN; SMALL INTERFERING RNA; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTHRITIS; ARTICLE; CARTILAGE DEGENERATION; CELL CULTURE; CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENZYME RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ARTHRITIS, RHEUMATOID; CALPAIN; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; HUMANS; MATRIX METALLOPROTEINASE 3; RNA INTERFERENCE; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33646186999     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.155     Document Type: Article

References (26)

1. Hegemann N., Wondimu A., Ullrich K., and Schmidt M.F. Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis. Vet. Immunol. Immunopathol. 91 (2003) 199-204
2. Yamamoto S., Shimizu K., Shimizu K., Suzuki K., Nakagawa Y., and Yamamuro T. Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints. Arthritis Rheum. 35 (1992) 1309-1317
3. Fujimori Y., Shimizu K., Suzuki K., Nakagawa Y., Yamamoto S., and Yamamuro T. Immunohistochemical demonstration of calcium-dependent cysteine proteinase (calpain) in collagen-induced arthritis in mice. Z. Rheumatol. 53 (1994) 72-75
4. Ishikawa H., Nakagawa Y., Shimizu K., Nishihara H., Matsusue Y., and Nakamura T. Inflammatory cytokines induced down-regulation of m-calpain mRNA expression in fibroblastic synoviocytes from patients with osteoarthritis and rheumatoid arthritis. Biochem. Biophys. Res. Commun. 266 (1999) 341-346
5. Suzuki K., Shimizu K., Hamamoto T., Nakagawa Y., Murachi T., and Yamamuro T. Characterization of proteoglycan degradation by calpain. Biochem. J. 285 (1992) 857-862
6. Oshita H., Sandy J.D., Suzuki K., Akaike A., Bai Y., Sasaki T., and Shimizu K. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain. Biochem. J. 382 (2004) 253-259
7. Szomor Z., Shimizu K., Fujimori Y., Yamamoto S., and Yamamuro T. Appearance of calpain correlates with arthritis and cartilage destruction in collagen induced arthritic knee joints of mice. Ann. Rheum. Dis. 54 (1995) 477-483
8. Catrina A.I., Lampa J., Ernestam S., af Klint E., Bratt J., Klareskog L., and Ulfgren A.K. Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology (Oxford) 41 (2002) 484-489
9. Sun H.B., and Yokota H. Altered mRNA level of matrix metalloproteinase-13 in MH7A synovial cells under mechanical loading and unloading. Bone 28 (2001) 399-403
10. Sun H.B., and Yokota H. Messenger-RNA expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and transcription factors in rheumatic synovial cells under mechanical stimuli. Bone 28 (2001) 303-309
11. Miyazawa K., Mori A., and Okudaira H. Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. J. Biochem. (Tokyo) 124 (1998) 1153-1162
12. Chen M., and Fernandez H.L. Mu-calpain is functionally required for alpha-processing of Alzheimer's beta-amyloid precursor protein. Biochem. Biophys. Res. Commun. 330 (2005) 714-721
13. Dohjima T., Lee N.S., Li H., Ohno T., and Rossi J.J. Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line. Mol. Ther. 7 (2003) 811-816
14. Nozawa S., Ohno T., Banno Y., Dohjima T., Wakahara K., Fan D.G., and Shimizu K. Inhibition of platelet-derived growth factor-induced cell growth signaling by a short interfering RNA for EWS-Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells. J. Biol. Chem. 280 (2005) 27544-27551
15. Fukui I., Tanaka K., and Murachi T. Extracellular appearance of calpain and calpastatin in the synovial fluid of the knee joint. Biochem. Biophys. Res. Commun. 162 (1989) 559-566
16. Fushimi K., Nakashima S., Banno Y., Akaike A., Takigawa M., and Shimizu K. Implication of prostaglandin E(2) in TNF-alpha-induced release of m-calpain from HCS-2/8 chondrocytes. Inhibition of m-calpain release by NSAIDs. Osteoarthritis Cartilage 12 (2004) 895-903
17. Akaike A., Banno Y., Osawa Y., Oshita H., Fushimi K., Kodama H., and Shimizu K. Synergistic induction of apoptosis of rheumatoid arthritis synovial cells by H(2)O(2) and N-acetyl-leucyl-leucyl-norleucinal. J. Orthop. Sci. 8 (2003) 346-351
18. Hasty K.A., Reife R.A., Kang A.H., and Stuart J.M. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum. 33 (1990) 388-397
19. Shimizu K., Hamamoto T., Hamakubo T., Lee W.J., Suzuki K., Nakagawa Y., Murachi T., and Yamamuro T. Immunohistochemical and biochemical demonstration of calcium-dependent cysteine proteinase (calpain) in calcifying cartilage of rats. J. Orthop. Res. 9 (1991) 26-36
20. Iwaki-Egawa S., Matsuno H., Yudoh K., Nakazawa F., Miyazaki K., Ochiai A., Hirohata S., Shimizu M., and Watanabe Y. High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen. J. Rheumatol. 31 (2004) 17-22
21. Lackner K.J., Schlosser U., Lang B., and Schmitz G. Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera. Br. J. Rheumatol. 37 (1998) 1164-1171
22. Mimori T., Suganuma K., Tanami Y., Nojima T., Matsumura M., Fujii T., Yoshizawa T., Suzuki K., and Akizuki M. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc. Natl. Acad. Sci. USA 92 (1995) 7267-7271
23. Sato S., Hasegawa M., Nagaoka T., Takamatsu Y., Yazawa N., Ihn H., Kikuchi K., and Takehara K. Autoantibodies against calpastatin in sera from patients with systemic sclerosis. J. Rheumatol. 25 (1998) 2135-2139
24. Yasuoka H., Sugano Y., Oka T., Watanabe C., Kaneko Y., Nojima T., Matsumura M., Fujii T., and Mimori T. Antigenic epitopes recognized by autoantibodies to calpastatin in patients with rheumatoid arthritis and their clinical significance. Ryumachi 37 (1997) 458-466
25. Evans C.H., Robbins P.D., Ghivizzani S.C., Wasko M.C., Tomaino M.M., Kang R., Muzzonigro T.A., Vogt M., Elder E.M., Whiteside T.L., Watkins S.C., and Herndon J.H. Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc. Natl. Acad. Sci. USA 102 (2005) 8698-8703
26. Gouze J.N., Stoddart M.J., Gouze E., Palmer G.D., Ghivizzani S.C., Grodzinsky A.J., and Evans C.H. In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. Methods Mol. Med. 100 (2004) 147-164